Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia.

Clicks: 60
ID: 278099
2022
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #45 of 83 articles by views in The Journal of antimicrobial chemotherapy

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Critical illness reduces β-lactam pharmacokinetic/pharmacodynamic (PK/PD) attainment. We sought to quantify PK/PD attainment in patients with hospital-acquired pneumonia.Meropenem plasma PK data (n = 70 patients) were modelled, PK/PD attainment rates were calculated for empirical and definitive targets, and between-patient variability was quantified [as a coefficient of variation (CV%)].Attainment of 100% T>4×MIC was variable for both empirical (CV% = 92) and directed (CV% = 33%) treatment.Individualization is required to achieve suggested PK/PD targets in critically ill patients.
Reference Key
rohani2022individualthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rohani, Roxane;Scheetz, Marc H;Donnelly, Helen K;Donayre, Alvaro;Kang, Mengjia;Diaz, Estefani;Dedicatoria, Kay;Hauser, Alan R;Ozer, Egon A;Nozick, Sophia;Qi, Chao;Pawlowski, Anna E;Neely, Michael N;Misharin, Alexander V;Wunderink, Richard G;Rhodes, Nathaniel J;, ;
Journal The Journal of antimicrobial chemotherapy
Year 2022
DOI
10.1093/jac/dkac245
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.